AfterRaise/Companies/Element Biosciences

Element Biosciences

Element Biosciences is a multi-disciplinary life science company that develops advanced DNA sequencing and multi-omics (the combined study of DNA, RNA, and proteins) technologies. From its funding announcement.

$175M Series ERaised 4 months agoSan Diego, USABiotech & PharmaUSA

In their own words

What Element Biosciences says it is doing

Work here? Claim your company profile

Public signal Described in the funding announcement as "multi-disciplinary life science company that develops advanced DNA sequencing and multi-omics (the combined study of DNA, RNA, and proteins) technologies". Source

Why now

Where Element Biosciences is today

Element Biosciences announced a Series E round of $175M on 10 June 2026.

Latest round
Series E
Amount
$175M
Announced
10 June 2026
Headquarters
San Diego, USA
Sector
Biotech & Pharma
Growth stage
Series C+
Investors
Not stated
Also participating
Not stated
Relevant leadership
Not stated

Momentum AfterRaise intelligence

AfterRaise Score

59
Steady growth
0 funding signals in the last 90 days
Funding recency
18/40
announced within the last 6 months
Round scale
22/25
round size relative to the market
Funding stage
19/20
Series E
Funding cadence
0/15
one funding event tracked this year
Arriving with the signals layer
  • Hiring momentum Open roles and hiring pace
  • Market expansion New offices and new countries
  • Leadership Executive appointments
  • Product activity Launches and releases

Since the raise

What has happened since

  • 10 June 2026
    $175M Series E
    Investors not stated in the announcement.

Public signal The timeline currently holds funding events, because those are the signals AfterRaise observes today. Hiring, leadership, expansion and product events join it with the signals layer.

What may happen next

What this raise could create

AfterRaise intelligenceNot a statement of fact

What may happen next

  • Aggressive multi-front expansion
  • Senior executive hiring
  • Multi-market operations
  • Executive appointments

Opportunities this could create

  • Clinical operations
  • Regulatory affairs
  • CMC and manufacturing
  • Quality systems
  • Medical affairs

Based on the Biotech & Pharma sector and a Series C+ round. Not a statement of fact.

Early momentum1 connected signal
  • 10 June 2026$175M Series E announced

High momentum means several meaningful company changes have occurred in a short period. Signals here are funding events and the priorities the company stated; hiring, leadership and expansion detection join with the signals layer.

Open to

What Element Biosciences is open to

Not yet specified

Element Biosciences has not told AfterRaise which approaches it welcomes. Until it does, we do not assume. Offers to help are held and shown to the company, and the company decides whether to open a conversation.

Work here? Set your preferences

Opportunities

Ways to work with Element Biosciences

No open opportunities listed

Jobs, projects, partnerships, advisory and supplier needs appear here once the company has claimed its page and published them, and any role we read from its own job board appears automatically.

Work here? Open the first one

Helpful contributors

People who have contributed here

Nobody yet

When someone offers help and the company says it was useful, they appear here. Reputation on AfterRaise is built from contributions the company confirmed, not from follower counts.

Do you work at Element Biosciences?

Claim your company profile.

This page was created from publicly available information. A verified representative corrects the record, says what the company is building next and chooses which conversations it welcomes.

What we do not have yet: your website, what the round is for, in your words, the roles and projects you have open and who leads the team. Claiming the page is how you fill those in.

Someone else requesting access does not give them ownership. Every representative is verified by a person before access is granted.

Maintaining your own company profile is free. A founder, CEO or authorised senior colleague can represent the company.

Also moving

Other Biotech & Pharma companies

See the sector